Recent advances in Staphylococcus aureus infection: focus on vaccine development
- PMID: 31190912
- PMCID: PMC6526327
- DOI: 10.2147/IDR.S175014
Recent advances in Staphylococcus aureus infection: focus on vaccine development
Abstract
Staphylococcus aureus normally colonizes the nasal cavity and pharynx. After breaching the normal habitat, the organism is able to cause a number of infections at any site of the body. The development of antibiotic resistance has created a global challenge for treating infections. Therefore, protection by vaccines may provide valuable measures. Currently, several vaccine candidates have been prepared which are either in preclinical phase or in early clinical phase, whereas several candidates have failed to show a protective efficacy in human subjects. Approaches have also been made in the development of monoclonal or polyclonal antibodies for passive immunization to protect from S. aureus infections. Therefore, in this review we have summarized the findings of recently published scientific literature to make a concise report.
Keywords: Staphylococcus aureus; active immunization; passive immunization; vaccine.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.mBio. 2016 Feb 2;7(1):e02232-15. doi: 10.1128/mBio.02232-15. mBio. 2016. PMID: 26838725 Free PMC article.
-
Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.mBio. 2018 Oct 16;9(5):e01949-18. doi: 10.1128/mBio.01949-18. mBio. 2018. PMID: 30327437 Free PMC article.
-
Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection.Sci Rep. 2015 Oct 22;5:15553. doi: 10.1038/srep15553. Sci Rep. 2015. PMID: 26490505 Free PMC article.
-
Vaccine development to prevent Staphylococcus aureus surgical-site infections.Br J Surg. 2017 Jan;104(2):e41-e54. doi: 10.1002/bjs.10454. Br J Surg. 2017. PMID: 28121039 Review.
-
Recent developments for Staphylococcus aureus vaccines: clinical and basic science challenges.Eur Cell Mater. 2015 Dec 2;30:315-26. doi: 10.22203/ecm.v030a22. Eur Cell Mater. 2015. PMID: 26629971 Review.
Cited by
-
Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired Staphylococcus aureus Infections.Microorganisms. 2023 Sep 6;11(9):2242. doi: 10.3390/microorganisms11092242. Microorganisms. 2023. PMID: 37764086 Free PMC article.
-
Killed whole-cell Staphylococcus aureus formulation in Montanide ISA266 and Alum adjuvants: different vaccine formulations varied in the vaccine's potency and efficacy.Immunol Res. 2025 Feb 7;73(1):47. doi: 10.1007/s12026-025-09602-z. Immunol Res. 2025. PMID: 39918699
-
Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed.Sci Rep. 2022 Mar 24;12(1):5140. doi: 10.1038/s41598-022-09195-9. Sci Rep. 2022. PMID: 35332241 Free PMC article.
-
An effective weapon against biofilm consortia and small colony variants of MRSA.Iran J Basic Med Sci. 2020 Nov;23(11):1494-1498. doi: 10.22038/ijbms.2020.46384.10712. Iran J Basic Med Sci. 2020. PMID: 33235708 Free PMC article.
-
Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections.Toxins (Basel). 2019 Sep 1;11(9):511. doi: 10.3390/toxins11090511. Toxins (Basel). 2019. PMID: 31480508 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources